Thumbnail - Request a copy

PSY72 – Orphan Drug Pricing In France: Influence of Main Factors

Grand, H.; Samson, Anne-Laure; Aulois-Griot, M. (2014), PSY72 – Orphan Drug Pricing In France: Influence of Main Factors, Value in Health, 17, 7, p. A534. 10.1016/j.jval.2014.08.1702

Type
Article accepté pour publication ou publié
Date
2014-11
Journal name
Value in Health
Volume
17
Number
7
Publisher
Elsevier
Pages
A534
Publication identifier
Metadata
Show full item record
Author(s)
Grand, H.

Samson, Anne-Laure
Laboratoire d'Economie de Dauphine [LEDa]
Aulois-Griot, M.
Abstract (EN)
Orphan drugs (OD) require considerable expenditures, which causes difficulties in their market access. For several years, the price of these new therapies has often been criticized and considered as too high. However few studies about OD pricing mechanisms are available. The aim of the paper is to highlight the main factors that influence OD pricing in France.
Subjects / Keywords
Drugs; Health expenditures
JEL
I12 - Health Behavior
I11 - Analysis of Health Care Markets